{"nctId":"NCT00178503","briefTitle":"Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children","startDateStruct":{"date":"2005-09"},"conditions":["Autism","Attention Deficit Disorder With Hyperactivity"],"count":24,"armGroups":[{"label":"MPH Trial-Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]},{"label":"MPH Trial: Low Dose","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Methylphenidate-extended release","Drug: Methylphenidate-immediate release"]},{"label":"MPH Trial: Med Dose","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Methylphenidate-extended release","Drug: Methylphenidate-immediate release"]},{"label":"MPH Trial: High Dose","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Methylphenidate-extended release","Drug: Methylphenidate-immediate release"]}],"interventions":[{"name":"Methylphenidate-extended release","otherNames":["Ritalin LA"]},{"name":"Methylphenidate-immediate release","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nAutism/ADHD Group:\n\n* DSM-IV diagnosis of autistic disorder, as per the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS)\n* Child manifests current symptoms of ADHD\n\nAutism/non-ADHD Group:\n\n* Meets the diagnostic criteria for autism, as above, but does not meet the diagnostic criteria for ADHD\n\nExclusion Criteria:\n\nIn both groups, exclusion criteria will include:\n\n* Sensory or motor deficits sufficient to interfere with testing (e.g., blindness, severe cerebral palsy)\n* Serious neurological disorders (e.g., epilepsy, stroke)\n* Down syndrome, fragile X syndrome, Tourette syndrome, or fetal alcohol syndrome\n* Bipolar disorder or a family history of bipolar disorder in a first-degree relative\n* Other serious psychopathology that resulted in psychiatric hospitalization (e.g., for psychotic episode). The investigators will screen for this using the Diagnostic Interview for Children and Adolescents (DICA)-IV, and getting a complete developmental/medical history\n* Serious physical handicaps that would interfere with performance on laboratory tasks\n* IQ less than 50 and greater than 130\n* Verbal mental age (VMA) less than 36 months (to exclude participants unable to understand simple task instructions)\n\nIn the autism/ADHD group, further exclusion criteria apply to the MPH trial:\n\n* History of intolerance to MPH\n* Weight less than 20 kg or greater than 59 kg (less than 44 pounds or greater than 130 pounds)\n* Concomitant use of dextroamphetamine preparations (Dexedrine, Dextrostat), mixed amphetamine salts (Adderall XR), other MPH preparations (e.g., Concerta, Metadate); venlafaxine, bupropion, atomoxetine, guanfacine, modafinil.\n* Concomitant use of any herbal preparations\n* Medical condition for which stimulants are contraindicated (e.g., high blood pressure)\n* Past treatment failure on a methylphenidate trial","healthyVolunteers":true,"sex":"ALL","minimumAge":"7 Years","maximumAge":"12 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Conners' Teacher ADHD Index T Score by Dose","description":"The ADHD Index of the Conners' Teacher Rating Scale-Revised (CTRS-R) assesses symptoms associated with ADHD, including inattentiveness, hyperactivity and impulsivity. Lower T-scores on this subscale are associated with milder ADHD symptoms. T-scores have a mean of 50 and a SD of 10. Thus, T-scores of 70+ (i.e., 2 SD's over the mean) on the ADHD Index are suggestive of very significant ADHD symptomatology. Treatment-related changes of 5+ points are considered to be significant.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.8","spread":"12.0"},{"groupId":"OG001","value":"63.1","spread":"11.2"},{"groupId":"OG002","value":"63.6","spread":"10.4"},{"groupId":"OG003","value":"61.5","spread":"13.0"}]}]}]},{"type":"PRIMARY","title":"Mean Continuous Performance Test (CPT)-Commission Errors by Dose","description":"CPT is a measure of sustained attention using nonverbal stimuli (pictures). Participants are asked to click on the witch (target), which appears for 25% of the trials. Commission errors are measured by number of times they click for the non-target items.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.75","spread":"3.49"},{"groupId":"OG001","value":"1.11","spread":"1.91"},{"groupId":"OG002","value":"1.18","spread":"1.71"},{"groupId":"OG003","value":"1.24","spread":"2.27"}]}]}]},{"type":"SECONDARY","title":"Mean Conners' Parent ADHD Index T Score by Week","description":"The ADHD Index of the Conners' Parent Rating Scale-Revised (CPRS-R) assesses symptoms associated with ADHD, including inattentiveness, hyperactivity and impulsivity. Lower T-scores on this subscale are associated with milder ADHD symptoms. T-scores have a mean of 50 and a SD of 10. Thus, T-scores of 70+ (i.e., 2 SD's over the mean) on the ADHD Index are suggestive of very significant ADHD symptomatology. Treatment-related changes of 5+ points are considered to be significant.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.1","spread":"12.0"},{"groupId":"OG001","value":"64.9","spread":"9.3"},{"groupId":"OG002","value":"62.3","spread":"10.0"},{"groupId":"OG003","value":"59.9","spread":"10.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Repetitive Behaviors","Repetitive Language","Irritability","Trouble sleeping","Loss of Appetite"]}}}